Fourth quarter earnings call

Anonymous

Guest
"...was 88.2%, up from 87.6% in fiscal 2014. The Vision Sciences gross margin..."

"...will be realized through a combination of..."

"...on a pro forma combined basis..."

"...such purchase price accounting adjustments..."
 






"...was 88.2%, up from 87.6% in fiscal 2014. The Vision Sciences gross margin..."

"...will be realized through a combination of..."

"...on a pro forma combined basis..."

"...such purchase price accounting adjustments..."

Two companies that never made a profit and lose money merge to form a what???

A DOG!!! Cogentix will be out of business soon. With flat MPQ and declining UPC (after Medtronic steals it all) Endosheath is not the savior.